Arcus Biosciences, Inc. (RCUS) insider trading

By person

16 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Gilead Sciences, Inc. entity

10% owner

—

31,424,760

$942.74M

+4.5%

Terry J Rosen

Chief Executive Officer

—

2,236,409

$67.09M

+6.4%

Juan C. Jaen

President

—

1,199,252

$35.98M

−21.2%

Jennifer Jarrett

Chief Operating Officer

—

224,024

$6.72M

+16.8%

Carolyn C. Tang

General Counsel

—

184,607

$5.54M

+60.1%

Richard Markus

Chief Medical Officer

—

89,647

$2.69M

—

Nuyten Dimitry SA

Chief Medical Officer

—

87,518

$2.63M

−8.2%

II Robert C. Goeltz

Chief Financial Officer

—

84,161

$2.52M

+14.0%

David L. Lacey

Director

—

76,652

$2.30M

+33.0%

Andrew J Perlman

Director

—

48,325

$1.45M

+64.8%

Kathryn E Falberg

Director

—

44,300

$1.33M

+75.1%

Patrick Machado

Director

—

44,300

$1.33M

+75.1%

Antoni Ribas

Director

—

44,300

$1.33M

+46.0%

Nicole Lambert

Director

—

43,000

$1.29M

+79.2%

Alexander Azoy

Chief Accounting Officer

—

39,581

$1.19M

+69.1%

Yasunori Kaneko

Director

—

25,700

$771.00K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Arcus Biosciences, Inc.

What the insiders did No buying or selling

By person